CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein

Journal of Cell Science

Volumn 125, Issue 22, 2012, Pages 5467-5478

  McGinn, Owen J ^a   Marinov, Georgi ^a   Sawan, Saladin ^a   Stern, Peter L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

5T4; Chemotaxis; CXCR7; EGFR; Proliferation; Signalling; Src; TPBG

Indexed keywords

5T4 ONCOFOETAL GLYCOPROTEIN; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CXCL12; CHEMOTAXIS; EMBRYO, MAMMALIAN; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CXCR; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA; SRC-FAMILY KINASES; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84873550100     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.109488     Document Type: Article

References (69)

1. Awan, A., Lucic, M. R., Shaw, D. M., Sheppard, F., Westwater, C., Lyons, S. A. and Stern, P. L. (2002). 5T4 interacts with TIP-2/GIPC, a PDZ protein, with implications for metastasis. Biochem. Biophys. Res. Commun. 290, 1030-1036.
2. Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y., Harriague, J., Moepps, B., Arenzana-Seisdedos, F., Thelen, M. and Bachelerie, F. (2005). The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280, 35760-35766.
3. Balkwill, F. (2004). The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 14, 171-179.
4. Begley, L. A., MacDonald, J. W., Day, M. L. and Macoska, J. A. (2007). CXCL12 activates a robust transcriptional response in human prostate epithelial cells. J. Biol. Chem. 282, 26767-26774.
5. Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M., Blaser, H., Minina, S., Wilson, D., Xu, Q. and Raz, E. (2008). Control of chemokine-guided cell migration by ligand sequestration. Cell 132, 463-473.
6. Burger, J. A. and Kipps, T. J. (2006). CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107, 1761-1767.
7. Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E., Sunshine, M. J., Littman, D. R., Kuo, C. J. et al. (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201-2213.
8. Cai, C. Q., Peng, Y., Buckley, M. T., Wei, J., Chen, F., Liebes, L., Gerald, W. L., Pincus, M. R., Osman, I. and Lee, P. (2008). Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations. Oncogene 27, 3201-3210.
9. Carsberg, C. J., Myers, K. A. and Stern, P. L. (1996). Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells. Int. J. Cancer 68, 84-92.
10. Castro, F. V., McGinn, O. J., Krishnan, S., Marinov, G., Li, J., Rutkowski, A. J., Elkord, E., Burt, D. J., Holland, M., Vaghjiani, R. et al. (2012). 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype. Leukemia 26, 1487-1498.
11. Chinni, S. R., Yamamoto, H., Dong, Z., Sabbota, A., Bonfil, R. D. and Cher, M. L. (2008). CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone. Mol. Cancer Res. 6, 446-457.
12. Cooper, J. A. and Howell, B. (1993). The when and how of Src regulation. Cell 73, 1051-1054.
13. D'Apuzzo, M., Rolink, A., Loetscher, M., Hoxie, J. A., Clark-Lewis, I., Melchers, F., Baggiolini, M. and Moser, B. (1997). The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27, 1788-1793.
14. Daaka, Y., Luttrell, L. M. and Lefkowitz, R. J. (1997). Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390, 88-91.
15. Dambly-Chaudiére, C., Cubedo, N. and Ghysen, A. (2007). Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev. Biol. 7, 23.
16. Dean, E. J., Cummings, J., Roulston, A., Berger, M., Ranson, M., Blackhall, F. and Dive, C. (2011). Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer. Neoplasia 13, 339-347.
17. Eastham, A. M., Spencer, H., Soncin, F., Ritson, S., Merry, C. L., Stern, P. L. and Ward, C. M. (2007). Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res. 67, 11254-11262.
18. Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W. and Groopman, J. E. (1998). The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J. Biol. Chem. 273, 23169-23175.
19. Goldmann, T., Drömann, D., Radtke, J., Marwitz, S., Lang, D. S., Schultz, H. and Vollmer, E. (2008). CXCR7 transcription in human non-small cell lung cancer and tumor-free lung tissues; possible regulation upon chemotherapy. Virchows Arch. 452, 347-348.
20. Graham, G. J. (2009). D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes. Eur. J. Immunol. 39, 342-351.
21. Hartmann, T. N., Grabovsky, V., Pasvolsky, R., Shulman, Z., Buss, E. C., Spiegel, A., Nagler, A., Lapidot, T., Thelen, M. and Alon, R. (2008). A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J. Leukoc. Biol. 84, 1130-1140.
22. Hole, N. and Stern, P. L. (1988). A 72 kD trophoblast glycoprotein defined by a monoclonal antibody. Br. J. Cancer 57, 239-246.
23. Honczarenko, M., Douglas, R. S., Mathias, C., Lee, B., Ratajczak, M. Z. and Silberstein, L. E. (1999). SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood 94, 2990-2998.
24. Huang, J., Sun, Y. and Huang, X. Y. (2004). Distinct roles for Src tyrosine kinase in beta2-adrenergic receptor signaling to MAPK and in receptor internalization. J. Biol. Chem. 279, 21637-21642.
25. Hubbard, S. R., Wei, L., Ellis, L. and Hendrickson, W. A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746-754.
26. Infantino, S., Moepps, B. and Thelen, M. (2006). Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J. Immunol. 176, 2197-2207.
27. Kalatskaya, I., Berchiche, Y. A., Gravel, S., Limberg, B. J., Rosenbaum, J. S. and Heveker, N. (2009). AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol. Pharmacol. 75, 1240-1247.
28. Kasina, S., Scherle, P. A., Hall, C. L. and Macoska, J. A. (2009). ADAM-mediated amphiregulin shedding and EGFR transactivation. Cell Prolif. 42, 799-812.
29. King, K. W., Sheppard, F. C., Westwater, C., Stern, P. L. and Myers, K. A. (1999). Organisation of the mouse and human 5T4 oncofoetal leucine-rich glycoprotein genes and expression in foetal and adult murine tissues. Biochim. Biophys. Acta 1445, 257-270.
30. Kobe, B. and Kajava, A. V. (2001). The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11, 725-732.
31. Kumar, A., Kumar, S., Dinda, A. K. and Luthra, K. (2004). Differential expression of CXCR4 receptor in early and term human placenta. Placenta 25, 347-351.
32. Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F. and Lagane, B. (2009). CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113, 6085-6093.
33. Luker, K. E., Gupta, M., Steele, J. M., Foerster, B. R. and Luker, G. D. (2009). Imaging ligand-dependent activation of CXCR7. Neoplasia 11, 1022-1035.
34. Luttrell, L. M., Ferguson, S. S., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F., Kawakatsu, H., Owada, K., Luttrell, D. K. et al. (1999). Betaarrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283, 655-661.
35. Mahabaleshwar, H., Boldajipour, B. and Raz, E. (2008). Killing the messenger: The role of CXCR7 in regulating primordial germ cell migration. Cell Adh. Migr. 2, 69-70.
36. Marchese, A. (2006). Assessment of degradation and ubiquitination of CXCR4, a GPCR regulated by EGFR family members. Methods Mol. Biol. 327, 139-145.
37. Mazzinghi, B., Ronconi, E., Lazzeri, E., Sagrinati, C., Ballerini, L., Angelotti, M. L., Parente, E., Mancina, R., Netti, G. S., Becherucci, F. et al. (2008). Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J. Exp. Med. 205, 479-490.
38. Miao, Z., Luker, K. E., Summers, B. C., Berahovich, R., Bhojani, M. S., Rehemtulla, A., Kleer, C. G., Essner, J. J., Nasevicius, A., Luker, G. D. et al. (2007). CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc. Natl. Acad. Sci. USA 104, 15735-15740.
39. Mulder, W. M., Stern, P. L., Stukart, M. J., de Windt, E., Butzelaar, R. M., Meijer, S., Adér, H. J., Claessen, A. M., Vermorken, J. B., Meijer, C. J. et al. (1997). Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients. Clin. Cancer Res. 3, 1923-1930.
40. Nagasawa, T., Nakajima, T., Tachibana, K., Iizasa, H., Bleul, C. C., Yoshie, O., Matsushima, K., Yoshida, N., Springer, T. A. and Kishimoto, T. (1996). Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc. Natl. Acad. Sci. USA 93, 14726-14729.
41. Porcile, C., Bajetto, A., Barbero, S., Pirani, P. and Schettini, G. (2004). CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line. Ann. N. Y. Acad. Sci. 1030, 162-169.
42. Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B. and Mackay, C. R. (1998). The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101, 746-754.
43. Raggo, C., Ruhl, R., McAllister, S., Koon, H., Dezube, B. J., Früh, K. and Moses, A. V. (2005). Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res. 65, 5084-5095.
44. Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., Gerard, C. and Lefkowitz, R. J. (2010). Beta-arrestin-but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc. Natl. Acad. Sci. USA 107, 628-632.
45. Schanz, A., Baston-Bust, D., Krussel, J. S., Heiss, C., Janni, W. and Hess, A. P. (2011). CXCR7 and syndecan-4 are potential receptors for CXCL12 in human cytotrophoblasts. J. Reprod. Immunol. 89, 18-25.
46. Schutyser, E., Su, Y., Yu, Y., Gouwy, M., Zaja-Milatovic, S., Van Damme, J. and Richmond, A. (2007). Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur. Cytokine Netw. 18, 59-70.
47. Shenoy, S. K., Barak, L. S., Xiao, K., Ahn, S., Berthouze, M., Shukla, A. K., Luttrell, L. M. and Lefkowitz, R. J. (2007). Ubiquitination of beta-arrestin links seventransmembrane receptor endocytosis and ERK activation. J. Biol. Chem. 282, 29549-29562.
48. Sierro, F., Biben, C., Martínez-Muñoz, L., Mellado, M., Ransohoff, R. M., Li, M., Woehl, B., Leung, H., Groom, J., Batten, M. et al. (2007). Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/ SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 104, 14759-14764.
49. Singh, R. K. and Lokeshwar, B. L. (2011). The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth. Cancer Res. 71, 3268-3277.
50. Sordella, R., Bell, D. W., Haber, D. A. and Settleman, J. (2004). Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305, 1163-1167.
51. Southall, P. J., Boxer, G. M., Bagshawe, K. D., Hole, N., Bromley, M. and Stern, P. L. (1990). Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br. J. Cancer 61, 89-95.
52. Southgate, T. D., McGinn, O. J., Castro, F. V., Rutkowski, A. J., Al-Muftah, M., Marinov, G., Smethurst, G. J., Shaw, D., Ward, C. M., Miller, C. J. et al. (2010). CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells. PLoS ONE 5, e9982.
53. Spencer, H. L., Eastham, A. M., Merry, C. L., Southgate, T. D., Perez-Campo, F., Soncin, F., Ritson, S., Kemler, R., Stern, P. L. and Ward, C. M. (2007). E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells. Mol. Biol. Cell 18, 2838-2851.
54. Starzynska, T., Marsh, P. J., Schofield, P. F., Roberts, S. A., Myers, K. A. and Stern, P. L. (1994). Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma. Br. J. Cancer 69, 899-902.
55. Starzynska, T., Wiechowska-Kozlowska, A., Marlicz, K., Bromley, M., Roberts, S. A., Lawniczak, M., Kolodziej, B., Zyluk, A. and Stern, P. L. (1998). 5T4 oncofetal antigen in gastric carcinoma and its clinical significance. Eur. J. Gastroenterol. Hepatol. 10, 479-484.
56. Struyf, S., Noppen, S., Loos, T., Mortier, A., Gouwy, M., Verbeke, H., Huskens, D., Luangsay, S., Parmentier, M., Geboes, K. et al. (2009). Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4. J. Immunol. 182, 666-674.
57. Sun, Y., McGarrigle, D. and Huang, X. Y. (2007). When a G protein-coupled receptor does not couple to a G protein. Mol. Biosyst. 3, 849-854.
58. Tarnowski, M., Grymula, K., Liu, R., Tarnowska, J., Drukala, J., Ratajczak, J., Mitchell, R. A., Ratajczak, M. Z. and Kucia, M. (2010). Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancerassociated fibroblasts. Mol. Cancer Res. 8, 1328-1343.
59. Tiveron, M. C. and Cremer, H. (2008). CXCL12/CXCR4 signalling in neuronal cell migration. Curr. Opin. Neurobiol. 18, 237-244.
60. Tripathi, V., Verma, R., Dinda, A., Malhotra, N., Kaur, J. and Luthra, K. (2009). Differential expression of RDC1/CXCR7 in the human placenta. J. Clin. Immunol. 29, 379-386.
61. Vandercappellen, J., Van Damme, J. and Struyf, S. (2008). The role of CXC chemokines and their receptors in cancer. Cancer Lett. 267, 226-244.
62. Wang, J., Shiozawa, Y., Wang, J., Wang, Y., Jung, Y., Pienta, K. J., Mehra, R., Loberg, R. and Taichman, R. S. (2008). The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J. Biol. Chem. 283, 4283-4294.
63. Ward, C. M., Barrow, K., Woods, A. M. and Stern, P. L. (2003). The 5T4 oncofoetal antigen is an early differentiation marker of mouse ES cells and its absence is a useful means to assess pluripotency. J. Cell Sci. 116, 4533-4532.
64. Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M. and Lefkowitz, R. J. (2003). Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. USA 100, 10782-10787.
65. Wrigley, E., McGown, A. T., Rennison, J., Swindell, R., Crowther, D., Starzynska, T. and Stern, P. L. (1995). 5T4 oncofetal antigen expression in ovarian carcinoma. Int. J. Gynecol. Cancer 5, 269-274.
66. Wu, M., Chen, Q., Li, D., Li, X., Li, X., Huang, C., Tang, Y., Zhou, Y., Wang, D., Tang, K. et al. (2008). LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. J. Cell. Biochem. 103, 245-255.
67. Zabel, B. A., Wang, Y., Lewén, S., Berahovich, R. D., Penfold, M. E., Zhang, P., Powers, J., Summers, B. C., Miao, Z., Zhao, B. et al. (2009). Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J. Immunol. 183, 3204-3211.
68. Zabel, B. A., Lewén, S., Berahovich, R. D., Jaén, J. C. and Schall, T. J. (2011). The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol. Cancer 10, 73.
69. Zhang, J., Sarkar, S. and Yong, V. W. (2005). The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis 26, 2069-2077.